Endocrinology Flashcards

1
Q

what embryological layer does the pancreas arise from

A

endoderm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

at what stage in embryological development does the pancreas first appear

A

week 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

at what stage in embryological development does there start to be an increase in the secretion of pancreatic hormones

A

week 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

at what week do the pancreatic cells start to differentiate and in what order does this happen

A

week 10

  1. alpha cells (glucagon)
  2. delta cells (somatostatin)
  3. beta cells (insulin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

at what week in embryological development is glucagon detectable in the fetal plasma

A

week 15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

explain physiology mechanism of how insulin is released

A
  1. GLUT2 transporters on the surface of beta cells allow influx of glucose into cells
  2. metabolism of glucose generates ATP in the cell cytoplasm > closes ATP-sensitive K cells
  3. causes depolarisation of the membrane and opening of voltage-gated Ca channels
  4. influx of Ca into cells which activates the mechanisms of exocytosis of insulin-containing vesicles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

diagnostic criteria for T1DM

A

random BM > 11.1

fasted BM > 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DR types linked to T1DM

A

HLA DR3 and DR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

suspected diabetes - not in DKA, appropriate management

A

refer on same day to paediatric diabetes service

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

annual monitoring done for T1DM

A

thyroid disease
eye screening
HbA1c (target <59)

From age 12:
albuminuria by urine albumin:creatinine ratio
+
hypertension screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is ‘somogyi effect’

A

night-time hypoglycaemia that manifests as fits, tremors, nightmares

causes rebound hyperglycaemia with glycosuria and ketonuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the ‘dawn phenomenon’

A

morning hyperglycamia caused by GH secretion, which peaks 4-5am

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is acanthosis nigricans and what does it signify

A

signifies insulin resistance

dry, dark patches of skin in the axilla, neck or groin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what causes acanthosis nigricans

A

increased circulating insulin acting at insulin-like growth factor (IGF-1) receptors, causing keratinocyte and fibroblast proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

annual monitoring in T2DM

A

triglycerides (usually up)

HDL (low)

non-HDL cholesterol (normal)

urine dipstick for albuminuria

diabetic retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

most common in inherited defect in monogenic diabetes

A

defect in hepatocyte nuclear factor (HNF)-1-alpha

17
Q

what % of T1DM present with DKA as their first feature

A

40%

18
Q

pathophysiology of DKA

A

insulin deficiency&raquo_space; increase in counter-regulatory hormones e.g. glucagon, cortisol, GH, catecholamines

no glucose is being metabolised so amino acid metabolism and lipolysis occur&raquo_space; incr leavels of protein and free fatty acids

the deficiency of insulin results in more glucose being produced (both gluconeogenesis and glycogenolysis)

the free fatty acids are converted by glucagon to ketones&raquo_space; metabolic acidosis

19
Q

2 main ketones in DKA

A

acetoacetic acid & beta-hydroxybutyric acid)

20
Q

what causes the pear drop smell on breath in DKA

A

metabolism of acetoacetic acid > acetone

21
Q

diagnostic criteria for DKA

A
  1. acidosis
  2. pH < 7.3 or bicarb < 15
  3. ketonaemia (blood beta-hydroxybutyrate > 3)
22
Q

classifications of DKA severity

A
  1. MILD
    > pH 7.2 - 7.29 +/- bicarb < 15
  2. MODERATE
    > pH 7.1 - 7.19 +/- bicarb < 10
  3. SEVERE
    > pH < 7.1 +/- bicarb < 5
23
Q

Rx DKA

A
  1. IVF (normal saline)
    > Fluid bolus 10ml/kg or 20ml/kg if shocked
    > Replacement fluids
    (deficit (over 48h) + maintenance (over 24h))
    > Hourly rate = (deficit - initial fluid bolus) / 48 + hourly maintenance rate
  2. INSULIN
    > Commence 1-2h after fluids
    > rate 0.05 - 0.1 units/kg/hr
    > stop continuous insulin pumps but keep long acting going
24
Q

Presumed fluid deficits in different severity of DKA

A

mild - 5%

moderate - 5%

severe - 10%

25
Q

when should dextrose be introduced into fluids in the management of DKA

A

when BM <14

26
Q

timings of stopping IV insulin and starting regular subcut insulin in Rx of DKA

A

Give the regular long acting insulin and stop the IV Insulin infusion 30 mins later

27
Q

major severe complication of DKA

A

cerebral oedema - consequence of fluid therapy

28
Q

what is included in a hypo screen

A

free fatty acids
insulin & c-peptide levels
beta-OH butyrate
cortisol
lactate
ammonia
acylcarnitines
urinary organic acids
plasma amino acids

29
Q

Rx hypo if no IV Access

A

Not drowsy - oral carbohydrate

Drowsy - IM glucagon

30
Q

Rx hypo if has IV access

A

2ml/kg 10% dextrose followed by IV maintenance fluids

31
Q

Rx of neonates with BM <1

A

IV 10% dex bolus 2.5ml/kg then 10% dextrose maintenance fluids

32
Q

mechanism of action - sulphonylureas

A

Act on the ATP sensing K+ channels in the beta cells

normally an increase in glucose leads to generation of ATP which is sensed by the ATP-K+ channels. Closure of the channels leads to increase in K which depolarises the membrane and leads to influx of Ca through the voltage gated channels with subsequent exocytosis of insulin

sulphonylureas increase the likelihood of the ATP-K channel closing, so augmenting the release of insulin

33
Q

mechanism of action - DPP4 inhibitors

A

decreases the action of incretins, hormones which lower blood glucose

34
Q

mechanism of action - GLP1 agonists

A

increases insulin sensitivity in peripheral cells

35
Q

mechanism of action - SGLT2

A

SGLT2 is a renal transports of glucose > reabsorbs 80-90% of glucose in the proximal convoluted tubule